Methods The curative effect of 160 multi-drug resistant pulmonary tuberculosis patients had been counted and analyze.
方法选择160例耐多药肺结核病人根据耐药情况进行统计学研究与回顾性分析。
ObjectiveTo explore the cause and treatment of multi-drug resistant pulmonary tuberculosis (MDR-TB) in patients with human immunodeficiency virus (HIV) infection.
目的了解人类免疫缺陷病毒(HIV)感染合并耐多药肺结核(MDR - TB)的成因及治疗效果。
Conclusion: Levofloxacin used in the treatment of the multi-drug resistant pulmonary tuberculosis is effective, and it is worthy of popularization and application.
结论：左氧氟沙星治疗耐多药肺结核效果显著，值得推广应用。
Conclusion the efficacy of bronchi artery injection bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis is obvious.
结论支气管动脉灌注，纤维支气管镜导管介入及化疗，耐多药肺结核疗效显著。
Objective To evaluate the clinical efficacy of a combination therapy with capreomycin , levofloxacin and sodium aminosalicylate in the treatment of multi-drug resistant pulmonary tuberculosis.
目的评价卷曲霉素、左氧氟沙星及对氨基水杨酸钠联合化疗方案在耐多药肺结核治疗中的效果。
Objective:To appraise the therapeutic effect of artificial pneumoperitoneum on multi drug resistant pulmonary tuberculosis(MDR PTB).
目的：探讨人工气腹疗法对耐多药肺结核（MDRPTB）的治疗价值。
And most important, is a multi-drug-resistant TB cases increased, the pulmonary tuberculosis patients a wide range of anti-tuberculosis drug resistance occurred.
而最重要的，莫过于是多耐药结核病例增加，病人肺内的结核菌对多种抗结核药物发生耐药。
And most important, is a multi-drug-resistant TB cases increased, the pulmonary tuberculosis patients a wide range of anti-tuberculosis drug resistance occurred.
而最重要的，莫过于是多耐药结核病例增加，病人肺内的结核菌对多种抗结核药物发生耐药。
应用推荐